| The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients V Matson, J Fessler, R Bao, T Chongsuwat, Y Zha, ML Alegre, JJ Luke, ... Science 359 (6371), 104-108, 2018 | 2789 | 2018 |
| Exploring the emerging role of the microbiome in cancer immunotherapy J Fessler, V Matson, TF Gajewski Journal for immunotherapy of cancer 7, 1-15, 2019 | 289 | 2019 |
| CometChip: a high-throughput 96-well platform for measuring DNA damage in microarrayed human cells J Ge, S Prasongtanakij, DK Wood, DM Weingeist, J Fessler, ... JoVE (Journal of Visualized Experiments), e50607, 2014 | 69 | 2014 |
| Micropatterned comet assay enables high throughput and sensitive DNA damage quantification J Ge, DN Chow, JL Fessler, DM Weingeist, DK Wood, BP Engelward Mutagenesis 30 (1), 11-19, 2015 | 49 | 2015 |
| Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity P Geeleher, A Nath, F Wang, Z Zhang, AN Barbeira, J Fessler, ... Genome Biology 19 (1), 130, 2018 | 36 | 2018 |
| More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens A Ling, RF Gruener, J Fessler, RS Huang Pharmacology & therapeutics 191, 178-189, 2018 | 36 | 2018 |
| The microbiota: a new variable impacting cancer treatment outcomes JL Fessler, TF Gajewski Clinical Cancer Research 23 (13), 3229-3231, 2017 | 29 | 2017 |
| PAK4 as a cancer immune-evasion target TF Gajewski, J Fessler Nature Cancer 1 (1), 18-19, 2020 | 14 | 2020 |
| Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction SJ Rouhani, JA Trujillo, AR Pyzer, J Yu, J Fessler, A Cabanov, EF Higgs, ... Research square, 2021 | 12 | 2021 |
| CometChip enables parallel analysis of multiple DNA repair activities J Ge, LP Ngo, S Kaushal, IJ Tay, E Thadhani, JE Kay, P Mazzucato, ... DNA repair 106, 103176, 2021 | 11 | 2021 |
| Abstract S04-02: Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection A Cabanov, BA Flood, J Bloodworth, EF Higgs, J Fessler, MYK Leung, ... Clinical Cancer Research 26 (18 Supplement), S04-02-S04-02, 2020 | 2 | 2020 |
| Abstract LB-C25: Inhibition of ERBB3 with MM-121, IGF1-R with MM-141 or Met with MM-131 increases the activity of EGFR inhibitor MM-151 in colorectal cancer models expressing … MJ Wainszelbaum, J Fessler, J Lahdenranta, O Burenkova, ... Molecular Cancer Therapeutics 14 (12 Supplement 2), LB-C25-LB-C25, 2015 | 2 | 2015 |
| DECREASED HOST PKC-DELTA IS ASSOCIATED WITH THE T CELL-INFLAMED TUMOR MICROENVIRONMENT AND IMPROVES ANTI-TUMOR IMMUNITY K Cron, A Sivan, K Aquino-Michaels, E Higgs, J Fessler, S Lee, R Sweis, ... Journal for ImmunoTherapy of Cancer 9, A671-A671, 2021 | 1 | 2021 |
| Genomic drivers of cancer are enriched and mutually exclusive within non-T cell-inflamed tumors B Olson, R Bao, J Fessler, J Luke, TF Gajewski, A Patnaik Cancer Research 78 (13 Supplement), 5737-5737, 2018 | 1 | 2018 |
| Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and therapeutic uses thereof TF Gajewski, J Luke, R Bao, V Matson, J Fessler US Patent App. 16/618,700, 2021 | | 2021 |
| The Gut Microbiome Shapes the Tumor Microenvironment by Tuning Innate Immunity JL Fessler The University of Chicago, 2021 | | 2021 |
| Abstract PO-067: Tissue banking from patients with SARS-CoV-2 (COVID-19) infection EF Higgs, BA Flood, AR Pyzer, SJ Rouhani, JA Trujillo, KR Cron, ... Clinical Cancer Research 26 (18 Supplement), PO-067-PO-067, 2020 | | 2020 |
| Cometchip: Enabling Translation of Dna Damage and Repair Assays. J Ge, JJ Tay, Y Su, P Mazzucato, DN Chow, J Fessler, DM Weingeist, ... Environmental & Molecular Mutagenesis 55, S37, 2014 | | 2014 |
| High-throughput Detection of Variations in Exposure-induced Dna Damage and Repair in Human Cells. J Ge, D Weingeist, D Wood, J Fessler, E Rowland Environmental & Molecular Mutagenesis 53 (1), S27, 2012 | | 2012 |